ARS Pharmaceuticals, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | — | $10.5M |
| Mar 2020 | — | — | $24.2M |
| Jun 2020 | — | — | $30.7M |
| Sep 2020 | — | — | $142.9M |
| Dec 2020 | $11.9M | $394.8M | $386.6M |
| Mar 2021 | $13.7M | $382.2M | $374.2M |
| Jun 2021 | $17.3M | $367.0M | $359.7M |
| Sep 2021 | $20.4M | $352.6M | $300.7M |
| Dec 2021 | $16.7M | $61.4M | $60.1M |
| Mar 2022 | $19.2M | $312.5M | $234.0M |
| Jun 2022 | $15.2M | $294.0M | $218.7M |
| Sep 2022 | $4.0M | $271.1M | $203.2M |
| Dec 2022 | $8.5M | $281.4M | $210.5M |
| Mar 2023 | $10.0M | $271.2M | $87.9M |
| Jun 2023 | $10.2M | $258.8M | $119.0M |
| Sep 2023 | $11.3M | $248.6M | $60.5M |
| Dec 2023 | $2.4M | $233.2M | $71.0M |
| Mar 2024 | $3.7M | $227.6M | $56.0M |
| Jun 2024 | $6.7M | $222.0M | $36.6M |
| Sep 2024 | $16.6M | $217.6M | $39.7M |
| Dec 2024 | $94.4M | $351.2M | $50.8M |
| Mar 2025 | $98.3M | $327.3M | $39.9M |
| Jun 2025 | $121.2M | $313.5M | $51.5M |
| Sep 2025 | $225.1M | $372.8M | $59.6M |
| Dec 2025 | $213.4M | $327.7M | $41.3M |
| Mar 2026 | $226.3M | $287.6M | $24.3M |
| Jun 2026 | $237.0M | $249.5M | $8.2M |